Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cancer of the esophagus is the seventh leading cause of cancer death worldwide. Esophageal carcinoma cell lines are useful models to study the biological and genetic alterations in these tumors. An important prerequisite of cell line research is the authenticity of the used cell lines because the mistaken identity of a cell line may lead to invalid conclusions. Estimates indicate that up to 36% of the cell lines are of a different origin or species than supposed. The TE series, established in late 1970s and early 1980s by Nishihira et al. in Japan, is one of the first esophageal cancer cell line series that was used throughout the world. Fourteen TE cell lines were derived from human esophageal squamous cell carcinomas and one, TE-7, was derived from a primary esophageal adenocarcinoma. In numerous studies, this TE-7 cell line was used as a model for esophageal adenocarcinoma because it is one of the few esophageal adenocarcinoma cell lines existing. We investigated the authenticity of the esophageal adenocarcinoma cell line TE-7 by xenografting, short tandem repeat profiling, mutation analyses, and array-comparative genomic hybridization and showed that cell line TE-7 shared the same genotype as the esophageal squamous cell carcinoma cell lines TE-2, TE-3, TE-12, and TE-13. In addition, for more than a decade, independent TE-7 cultures from Japan, United States, United Kingdom, France, and the Netherlands had the same genotype. Examination of the TE-7 cell line xenograft revealed the histology of a squamous cell carcinoma. We conclude that the TE-7 cell line, used in several laboratories throughout the world, is not an adenocarcinoma, but a squamous cell carcinoma cell line. Furthermore, the cell lines TE-2, TE-3, TE-7, TE-12, and TE-13 should be regarded as one single squamous cell carcinoma cell line. [Cancer Res 2007;67(17):7996–8001]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Short tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478 · cited 1×
“Furthermore, loss of one allele at FGA and D8S1179 loci was also described in cross-contaminants of HeLa cells, indicating that allelic loss frequently occurs at these particular loci (4).”
Human cancer cell lines: fact and fantasy
Masters, J. R. W. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043102 · Cited by 352 · cited 1×
“An important prerequisite of cell line research is the authenticity of the used cell lines because the mistaken identity of a cell line may lead to invalid conclusions (3).”
Cancer cell line identification by short tandem repeat profiling: power and limitations
Parson, W., Kirchebner, R., Mühlmann, R., Renner, K., Kofler, A., Schmidt, S., & Kofler, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3062fje · Cited by 129
Cited by
Li, X., Francies, H. E., Secrier, M., Perner, J., Miremadi, A., Galeano-Dalmau, N., Barendt, W. J., Letchford, L., Leyden, G. M., Goffin, E. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05190-9 · Cited by 316
Choosing the right cell line for renal cell cancer research
Brodaczewska, K. K., Szczylik, C., Fiedorowicz, M., Porta, C., & Czarnecka, A. M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0565-8 · Cited by 267
High‐throughput SNP‐based authentication of human cell lines
Castro, F., Dirks, W. G., Fähnrich, S., Hotz‐Wagenblatt, A., Pawlita, M., & Schmitt, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27675 · Cited by 183
Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines
Boonstra, J. J., van Marion, R., Beer, D. G., Lin, L., Chaves, P., Ribeiro, C., Pereira, A. D., Roque, L., Darnton, S. J., Altorki, N. K., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp499 · Cited by 127
Self-citationAuthentication of nasopharyngeal carcinoma tumor lines
Chan, S. Y., Choy, K., Tsao, S., Tao, Q., Tang, T., Chung, G. T., & Lo, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23374 · Cited by 119
Metadata
- Authors
- Boonstra, J. J., van der Velden, A. W., Beerens, E. C. W., van Marion, R., Morita-Fujimura, Y., Matsui, Y., Nishihira, T., Tselepis, C., Hainaut, P., Lowe, A. W., Beverloo, B. H., van Dekken, H., Tilanus, H. W., & Dinjens, W. N. M.
- Venue
- Cancer Research
- Published
- 2007-09-01
- Volume
- 67
- Issue
- 17
- Pages
- 7996-8001
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1974048869
- Cited by
- 50
- References
- 3
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2064
- The paper
- Boonstra, J. J., van der Velden, A. W., Beerens, E. C. W., van Marion, R., Morita-Fujimura, Y., Matsui, Y., Nishihira, T., Tselepis, C., Hainaut, P., Lowe, A. W., Beverloo, B. H., van Dekken, H., Tilanus, H. W., & Dinjens, W. N. M. (2007). Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.